163
Participants
Start Date
September 10, 2016
Primary Completion Date
June 1, 2021
Study Completion Date
June 1, 2021
Evolocumab
Administered by subcutaneous injection
Research Site, Ljubljana
Research Site, Vienna
Research Site, Budapest
Research Site, Geneva
Research Site, Camperdown
Research Site, Parktown
Research Site, Leuven
Research Site, Reinach
Research Site, Salzburg
Research Site, Bergen
Research Site, Feldkirch
Research Site, La Louvière
Research Site, Parow
Research Site, Ghent
Research Site, Torino
Research Site, The Bronx
Research Site, Córdoba
Research Site, A Coruña
Research Site, Kota Bharu
Research Site, Athens
Research Site, Lugo
Research Site, Izmir
Research Site, Nashville
Research Site, Cincinnati
Research Site, Thessaloniki
Research Site, Pisa
Research Site, Bucaramanga
Research Site, Palermo
Research Site, Saint Petersburg
Research Site, Fortaleza
Research Site, Brasília
Research Site, São Paulo
Research Site, São Paulo
Research Site, Chicoutimi
Research Site, Chicoutimi
Research Site, Québec
Research Site, Barranquilla
Research Site, Svitavy
Research Site, Roma
Research Site, Roma
Research Site, Amsterdam
Research Site, Oslo
Research Site, Gdansk
Research Site, Guimarães
Research Site, Ankara
Research Site, Birmingham
Lead Sponsor
Amgen
INDUSTRY